Tcw Group Inc Gilead Sciences, Inc. Transaction History

Tcw Group Inc

$9.73 Billion
Q1 2024

A detailed history of Tcw Group Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tcw Group Inc holds 559,711 shares of GILD stock, worth $38.3 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

559,711

Previous 555,133 0.82%

Holding current value

$38.3 Million

Previous $45 Million 8.83%

% of portfolio

0.42%

Previous 0.51%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $327,693 - $399,613	4,578 Added 0.82%	559,711 $41 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $208,966 - $236,972	2,852 Added 0.52%	555,133 $45 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $9.82 Million - $10.7 Million	-132,753 Reduced 19.38%	552,281 $41.4 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $6.06 Million - $6.91 Million	79,757 Added 13.18%	685,034 $52.8 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2 Million - $2.28 Million	25,873 Added 4.47%	605,277 $50.2 Million

Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $641,771 - $921,362	10,298 Added 1.81%	579,404 $49.7 Million
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $3.93 Million - $4.49 Million	66,089 Added 13.14%	569,106 $35.1 Million
Q2 2022 Jul 19, 2022	SELL	$57.72 - $65.01 $7.06 Million - $7.95 Million	-122,282 Reduced 19.56%	503,017 $31.1 Million
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $4.28 Million - $5.36 Million	-73,846 Reduced 10.56%	625,299 $37.2 Million
Q4 2021 Jan 26, 2022	BUY	$64.88 - $73.64 $1.67 Million - $1.9 Million	25,768 Added 3.83%	699,145 $50.8 Million
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $455,215 - $491,126	-6,725 Reduced 0.99%	673,377 $47 Million
Q2 2021 Jul 23, 2021	SELL	$63.47 - $69.35 $3 Million - $3.28 Million	-47,332 Reduced 6.51%	680,102 $46.8 Million
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $2.69 Million - $3.07 Million	-44,829 Reduced 5.8%	727,434 $47 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $2.71 Million - $3.09 Million	-47,824 Reduced 5.83%	772,263 $45 Million
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $394,335 - $495,808	-6,350 Reduced 0.77%	820,087 $51.8 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $8.88 Million - $10.3 Million	-122,749 Reduced 12.93%	826,437 $63.6 Million
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $7.48 Million - $9.59 Million	-119,504 Reduced 11.18%	949,186 $71 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $5.57 Million - $6.13 Million	-90,371 Reduced 7.8%	1,068,690 $69.4 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $9.01 Million - $9.95 Million	-144,140 Reduced 11.06%	1,159,061 $73.5 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $33.3 Million - $37.3 Million	-537,453 Reduced 29.2%	1,303,201 $88 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $6.15 Million - $6.89 Million	-98,326 Reduced 5.07%	1,840,654 $120 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $7.17 Million - $9.35 Million	-118,409 Reduced 5.76%	1,938,980 $121 Million
Q3 2018 Oct 30, 2018	SELL	$71.28 - $78.92 $19.2 Million - $21.2 Million	-268,717 Reduced 11.55%	2,057,389 $159 Million
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $901,053 - $1.05 Million	-13,888 Reduced 0.59%	2,326,106 $165 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $4.88 Million - $5.95 Million	67,019 Added 2.95%	2,339,994 $176 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $6.23 Million - $7.31 Million	-87,543 Reduced 3.71%	2,272,975 $163 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $18.9 Million - $22.4 Million	262,162 Added 12.49%	2,360,518 $191 Million
Q2 2017 Aug 11, 2017	BUY	N/A	2,098,356	2,098,356 $149 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Account